Ido Kanyon has more than 15 years of senior executive experience within the pharmaceutical industry. Mr Kanyon began his career in agriculture research and Agritech R&D field. He then joined a publicly-traded medical device startup covering R&D, intellectual property and business development. Mr Kanyon holds a Bachelor of Science in Agriculture (Botany) from The Hebrew University of Jerusalem, and an MBA from IE Business School in Spain. He was the global head of specialty pipeline, global marketing and portfolio at Teva headquarters in the US where he was responsible for the company’s specialty medicine multi-billion specialty pipeline portfolio. He also served as a global commercial senior director for Teva’s respiratory business, driving commercial growth for the firm’s respiratory franchise, and had held several quality assurance and regulatory affairs leadership roles within the company. Mr Kanyon joined Auscann Group in May 2019, taking the helm as chief executive, until his departure in August 2020.
